Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,839 | 0 | 0 | 0 | 64,520 |
| Receivables | 88,283 | 0 | 0 | 0 | 85,128 |
| Inventories | 29,120 | 0 | 0 | 0 | 27,326 |
| Other current assets | 0 | 0 | 0 | 0 | 6,059 |
| TOTAL | $211,794 | $0 | $0 | $0 | $183,033 |
| Non-Current Assets | |||||
| PPE Net | 6,879 | N/A | N/A | N/A | 22,731 |
| Investments And Advances | 19,382 | 0 | 0 | 0 | 0 |
| Intangibles | 241,450 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 14,961 | 0 | 0 | 0 | 0 |
| TOTAL | $282,672 | $N/A | $N/A | $N/A | $22,731 |
| Total Assets | $494,466 | $0 | $0 | $0 | $472,407 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,000 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 4,422 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 99,241 | 0 | 0 | 0 | 0 |
| Other current liabilities | 3,926 | 0 | 0 | 0 | 0 |
| TOTAL | $122,589 | $0 | $0 | $0 | $89,015 |
| Non-Current Liabilities | |||||
| Long Term Debt | 173,378 | 0 | 0 | 0 | 187,965 |
| Other Non-Current Liabilities | 51,502 | 492 | 214 | 458 | 0 |
| TOTAL | $227,717 | $N/A | $N/A | $N/A | $187,965 |
| Total Liabilities | $350,306 | $0 | $0 | $0 | $326,790 |
| Shareholders' Equity | |||||
| Retained earnings | N/A | 0 | 0 | 0 | -141,700 |
| Other shareholders' equity | 144,160 | 0 | 0 | 0 | 287,317 |
| TOTAL | $144,160 | $0 | $0 | $0 | $145,617 |
| Total Liabilities And Equity | $494,466 | $0 | $0 | $0 | $472,407 |